MedTrace Logo

The HOPE Trial and the SMART Study

NCT03022032 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2025-09-09

Study results available
· View outcomes & findings →

Summary

This research study is evaluating a new smartphone application named the "Helping Our Patients Excel (HOPE)" app with a Fitbit device. The SMART Study is a sub-study of the HOPE Trial. Both studies evaluate an almost identical intervention using a Fitbit device and smartphone app(s) with the goal of improving quality-of-life for women with gynecologic cancers.

Conditions

  • Gynecologic Cancer

Interventions

DEVICE

Fitbit Zip

Fitbit Zip

OTHER

HOPE App

HOPE App

OTHER

Standard of Care

Standard of Care

DEVICE

Fitbit Charge 2

Fitbit Charge 2

OTHER

SMART Study Intervention

SMART study app + Beiwe study app + Fitbit

Sponsors & Collaborators

Principal Investigators

  • Alexi A Wright, MD MPH · Dana-Farber Cancer Institute

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-12
Primary Completion
2020-09-02
Completion
2020-09-02

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03022032 on ClinicalTrials.gov